Tuesday, June 26, 2018 3:57:16 PM
Shanxi Weinan Huaren Pharmaceuticals has been claimed to be bought by Guang Dong Jian Quan in January 2017, see http://www.healthr.com/company/50FSo/
Now that is quite interesting (o8>
Weinan was bought in 2011 for roughly 61M RMB or $9.6M
and is now claimed to have asset value of around
"Shaanxi Weinan Huaren Pharmaceutical Co., Ltd. covers an area of 50 acres, a registered capital of 80 million yuan"
It would explain how company was able to renovate Shanxi Aoxing, get the GMP license back in Dec'17 and already kicked of production and sales.
Since the letter was very unlikely to happen while certain assets were claimed by creditors!
Conclusion based on previously posted proof that sales of new production occurs: They are clean by now.
So .. again, waiting for the audited 10-K.
GL
PS: Not a pump, but speculation based on this DD
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM